C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
JARI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/03/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
07/10/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
JOHNSON, AISHA CLARKE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Jiangsu Automation Research Institute
Representatives
Lianyungang Guangxin Shangbiao Shiwusuo
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for medical or veterinary purposes for the prevention and treatment of cancer; balsamic preparations for medical purposes for the prevention and treatment of cancer; medicines for alleviating constipation; digestives for pharmaceutical purposes; laxative; ointments for pharmaceutical purposes for the prevention and treatment of cancer; tranquillizers; sedatives; soporific; biological preparations for medical purposes for the prevention and treatment of cancer; chemical preparations for medical purposes for the prevention and treatment of cancer; enzymes for medical purposes; pharmaceutical preparations in the form of injectiontabletaqueous formulationtincturecapsuleointmentfor the prevention and treatment of cancerfor the treatment of cardiovascular and cardiopulmonary disordersprevention and treatment of disorders of the nervous systemthe immune systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary systemfor the treatment of inflammatory disorders; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; anti-epileptic pharmaceutical preparations; anti-cancer preparations
Class 42
Technical research in the field of pharmaceutical studies; technical project studiesin the field of pharmaceutical studies; scientific laboratory services; oil-well testing; geological prospecting; oil prospecting; computer programming; computer software design; consultancy in the design and development of computer hardware; maintenance of computer software; computer system analysis; computer system design; conversion of computer programs and dataother than physical conversion; monitoring of computer systems by remote access to ensure proper functioning; engineering; Providing quality checking and testing of products; Providing quality checking and testing of products in the field of engineering; Providing quality assessment services in the field of product engineering; quality control services for certification purposes in the field of engineering; updating of computer software; rental of computer software; recovery of computer data; creating and maintaining web sites for others; web site hosting services; installation of computer software; computer software consultancy
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2019
FIMP
FINAL DISPOSITION PROCESSED
11/18/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/31/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2019
NPUB
NOTICE OF PUBLICATION
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2019
RFNP
REFUSAL PROCESSED BY IB
12/21/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/23/2018
RFRR
REFUSAL PROCESSED BY MPU
11/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/09/2018
CNRT
NON-FINAL ACTION WRITTEN
11/08/2018
DOCK
ASSIGNED TO EXAMINER
10/27/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/11/2018
FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
09/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/04/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/23/2018
Continuous trademark protection
Get notified about every new filing that threatens JARI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.